Crescent Grove Advisors, LLC Merck & Co., Inc. Transaction History
Crescent Grove Advisors, LLC
- $931 Million
- Q1 2024
A detailed history of Crescent Grove Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Crescent Grove Advisors, LLC holds 14,907 shares of MRK stock, worth $1.88 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
14,907
Previous 14,904
0.02%
Holding current value
$1.88 Million
Previous $1.62 Million
21.06%
% of portfolio
0.21%
Previous 0.19%
Shares
27 transactions
Others Institutions Holding MRK
# of Institutions
3,768Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.6 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26.1 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.8 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.9 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.1 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $319B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...